GENOCEA BIOSCIENCES INC's ticker is GNCA and the CUSIP is 372427401. A total of 39 filers reported holding GENOCEA BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $3,591,000 | +1058.4% | 1,325,184 | +933.7% | 0.05% | +1050.0% |
Q4 2020 | $310,000 | +4.7% | 128,203 | -0.8% | 0.00% | -20.0% |
Q3 2020 | $296,000 | -90.4% | 129,229 | -90.4% | 0.01% | -89.4% |
Q2 2020 | $3,081,000 | +2.5% | 1,339,502 | -23.4% | 0.05% | -21.7% |
Q1 2020 | $3,007,000 | -18.9% | 1,748,337 | -2.4% | 0.06% | +22.4% |
Q4 2019 | $3,707,000 | -28.6% | 1,791,003 | +0.1% | 0.05% | -34.7% |
Q3 2019 | $5,191,000 | -26.3% | 1,789,899 | -0.3% | 0.08% | -17.6% |
Q2 2019 | $7,041,000 | – | 1,796,062 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 1,765,901 | $4,273,000 | 2.32% |
NEA Management Company, LLC | 10,376,936 | $25,112,000 | 0.66% |
Polaris Venture Management Co. V, L.L.C. | 197,345 | $478,000 | 0.62% |
ABG Innovation Capital Partners III GP Ltd | 375,000 | $908,000 | 0.54% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,972,056 | $4,772,000 | 0.52% |
BVF INC/IL | 4,012,404 | $9,710,000 | 0.38% |
Avoro Capital Advisors LLC | 5,084,184 | $12,304,000 | 0.21% |
FNY Investment Advisers, LLC | 200,000 | $484,000 | 0.13% |
Boxer Capital, LLC | 1,134,453 | $2,745,000 | 0.09% |
GSA CAPITAL PARTNERS LLP | 130,745 | $316,000 | 0.05% |